COVID-19 atypical Parsonage-Turner syndrome: a case report

BMC Neurol. 2022 Mar 16;22(1):96. doi: 10.1186/s12883-022-02622-4.

Abstract

Background: Neurological manifestations of Sars-CoV-2 infection have been described since March 2020 and include both central and peripheral nervous system manifestations. Neurological symptoms, such as headache or persistent loss of smell and taste, have also been documented in COVID-19 long-haulers. Moreover, long lasting fatigue, mild cognitive impairment and sleep disorders appear to be frequent long term neurological manifestations after hospitalization due to COVID-19. Less is known in relation to peripheral nerve injury related to Sars-CoV-2 infection.

Case presentation: We report the case of a 47-year-old female presenting with a unilateral chest pain radiating to the left arm lasting for more than two months after recovery from Sars-CoV-2 infection. After referral to our post-acute outpatient service for COVID-19 long haulers, she was diagnosed with a unilateral, atypical, pure sensory brachial plexus neuritis potentially related to COVID-19, which occurred during the acute phase of a mild Sars-CoV-2 infection and persisted for months after resolution of the infection.

Conclusions: We presented a case of atypical Parsonage-Turner syndrome potentially triggered by Sars-CoV-2 infection, with symptoms and repercussion lasting after viral clearance. A direct involvement of the virus remains uncertain, and the physiopathology is unclear. The treatment of COVID-19 and its long-term consequences represents a relatively new challenge for clinicians and health care providers. A multidisciplinary approach to following-up COVID-19 survivors is strongly advised.

Keywords: Atypical brachial plexus neuritis; COVID-19 neurological manifestations; COVID-19 neuromuscular sequelae; Sars-CoV-2 infection.

Publication types

  • Case Reports

MeSH terms

  • Brachial Plexus Neuritis* / diagnosis
  • Brachial Plexus Neuritis* / etiology
  • Brachial Plexus Neuritis* / therapy
  • COVID-19* / complications
  • Female
  • Humans
  • Middle Aged
  • SARS-CoV-2